CEI
Clark Estates Inc Portfolio holdings
AUM
$446M
1-Year Est. Return
6.99%
1 Year Est. Return
+6.99%
AUM
$472M
AUM Growth
-$45.1M
(-8.7%)
Holding
104
Top Buys
| 1 | +$16.8M | |
| 2 | +$10.4M | |
| 3 | +$7.08M | |
| 4 |
DNB
Dun & Bradstreet
DNB
|
+$3.9M |
| 5 |
J.M. Smucker
SJM
|
+$2.49M |
Top Sells
| 1 | +$8.95M | |
| 2 | +$6.86M | |
| 3 | +$6.62M | |
| 4 |
Philip Morris
PM
|
+$5.56M |
| 5 |
Euclidean Fundamental Value ETF
ECML
|
+$5.28M |
Sector Composition
| 1 | Healthcare | 35.59% |
| 2 | Consumer Staples | 16.24% |
| 3 | Technology | 10.52% |
| 4 | Financials | 5.44% |
| 5 | Communication Services | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Euclidean Fundamental Value ETF
ECML
$131M
| $96.6M | 20.45% |
3,151,696
-172,245
|
|
||
2
Baxter International
BAX
$11.7B
| $25.7M | 5.44% |
750,000
-25,000
|
|
||
3
Smith & Nephew
SNN
$15.2B
| $24.1M | 5.11% |
850,000
+50,000
|
|
||
|
DNB
4
DELISTED
Dun & Bradstreet
DNB
| $23.9M | 5.05% |
2,667,886
+435,896
|
|
||
5
Medtronic
MDT
$122B
| $22.5M | 4.76% |
250,000
|
|
||
6
Haleon
HLN
$41.8B
| $20.6M | 4.36% |
2,000,000
|
|
||
7
Kenvue
KVUE
$29.4B
| $20.4M | 4.32% |
850,000
|
|
||
8
Diageo
DEO
$54.1B
| $19.4M | 4.1% |
185,000
+99,500
|
|
||
9
IQVIA
IQV
$34.8B
| $16.8M | 3.55% |
+95,200
|
|
||
10
Sony
SONY
$172B
| $15.2M | 3.23% |
600,000
-100,000
|
|
||
11
Unilever
UL
$154B
| $14M | 2.96% |
235,000
|
|
||
12
Bausch + Lomb
BLCO
$5.27B
| $9.02M | 1.91% |
622,000
+22,000
|
|
||
|
13
Philip Morris
PM
$247B
| $7.98M | 1.69% |
50,300
-35,000
|
|
||
14
Avanos Medical
AVNS
$532M
| $7.08M | 1.5% |
+493,880
|
|
||
15
Alphabet (Google) Class A
GOOGL
$3.04T
| $6.41M | 1.36% |
41,420
|
|
||
16
Fiserv
FI
$65.3B
| $5.59M | 1.18% |
25,300
-30,000
|
|
||
17
Catalyst Pharmaceutical
CPRX
$2.5B
| $3.26M | 0.69% |
134,418
-51,325
|
|
||
18
3D Systems Corp
DDD
$412M
| $3.01M | 0.64% |
1,418,614
|
|
||
19
Pediatrix Medical
MD
$1.42B
| $2.96M | 0.63% |
204,613
-78,127
|
|
||
20
Altria Group
MO
$108B
| $2.92M | 0.62% |
48,613
-18,447
|
|
||
21
Gilead Sciences
GILD
$150B
| $2.92M | 0.62% |
26,022
-9,908
|
|
||
22
Heidrick & Struggles
HSII
$1.21B
| $2.89M | 0.61% |
67,387
-25,730
|
|
||
23
Halozyme
HALO
$7.81B
| $2.86M | 0.61% |
44,868
-17,132
|
|
||
24
Perdoceo Education
PRDO
$2.27B
| $2.6M | 0.55% |
103,403
-39,483
|
|
||
25
John Wiley & Sons Class A
WLY
$1.97B
| $2.55M | 0.54% |
57,252
-21,861
|
|